2020 is such a special year that we almost forgot to celebrate the 10th anniversary of IPStudies patent analytics activities… the local party is postponed to a later, post-COVID date, but we’d still like to take a look back at our first ten years of practice. Back in September 2010, patent mining and landscaping tools were still in their infancy, limited to basic quantitative counts over time and classes. Having experimented the benefit of using patent analytics data to guide R&D as well as M&A development choices in the high-tech corporate world, IPStudies’s founder, Corinne Le Buhan, envisioned the need to bring this information to Swiss technology “grown-ups” as early as possible in their product development cycle. By going beyond the extraction of austere lists of patent numbers to visually highlight their development context, it becomes much easier to benchmark and thus optimize the IP development positioning for companies exposed to highly competitive environments.
Continue readingTag: patent landscape
June 2017 – Acceleration of the CRISPR patent landscape growth
Three years ago, we finalized our first CRISPR patent landscape analysis, at that time combined with an analysis of the TALE patent landscape which was then significantly larger. There were only 90 CRISPR patent families in this early analysis… that is less than the whole set of new CRISPR patent publications in the past single month: 116 additional patent families in our latest CRISPR patent analytics data set.
The IPStudies 2017 CRISPR patent landscape is out, don’t miss it!
The CRISPR patent landscape keeps on developing at an increasing pace in 2017, with now up to three new patent families published every day! We have searched, reviewed and categorized more than 1146 patent families, now surveyed in our just released 2017 CRISPR patent landscape report.
CRISPR patents – the raise of China
What is the latest IP situation of the People’s Republic of China in the CRISPR patent landscape? As announced in major media in April 2015, Chinese academic researchers have edited the genome of non-viable human embryos using the CRISPR/Cas9 system, triggering the on-going debates on human genome engineering ethical aspects. The presence of Chinese players, both academic and industrial, in the CRISPR patent landscape is also confirmed by our recent findings.
IP management practices – Findings from the CRISPR-Cas landscape
When initially building our CRISPR-Cas patent landscape database over this summer, we were surprised by some unusual inventor patterns. As we now monitoring deeper into this data subset for our customers, we are further amazed by how some inventors and applicants are already strongly defending their IP position by various means in the diversity of international patent prosecution law practices – an IP management lesson of its own!
TAL Effectors and CRISPR-Cas patent survey
We’re pleased the announce the availability of new IPStudies patent landscapes on TAL Effectors and CRISPR-CAS, two outstanding and competing genome engineering technologies that have raised significant investments in academic as well as industrial research in the past 5 years.
Our TAL Effectors and CRISPR-Cas patent landscapes analyze worldwide published patent families regarding:
- Transcription Activator-Like effectors (TAL Effectors – TALE), including genome editing methods based on TALE Nucleases (TALEN);
- Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR), including genome editing methods based on the emerging CRISPR-Cas9 systems breakthrough technology.
The survey comprises:
- a global patent database (265 patent families) comprising both TAL Effectors and CRISPR, in order to give an overall overview of the IP situation, including the comparison of patent filings and the technological positioning of actors on either TAL Effectors or CRISPR or both;
- a focus on TALE Effectors (197 patent families), including TALE Nucleases;
- a focus on CRISPR (96 patent families), including CRISPR-Cas9 nucleases.
For more information, survey sample and order form, please check our dedicated page here.
IPStudies launches independent patent orienteering surveys
In addition to our exclusive customer services, we now offer a selection of independent patent orienteering™ surveys on emerging breakthrough technologies, identified from our research network, searched in professional patent databases and carefully analyzed by our PhD experts.
Our patent studies are designed to help R&D, IP and business development managers identify and visualize key patent information around a given technology, to support strategic decisions by highlighting the right information out of the patent big data.
Each patent orienteering™ survey includes:
- an analysis of the patent landscape, covering hundreds of published patent families, worldwide, in a given technology area;
- a synthesis of IP strategy findings, to visualize key trends in terms of patent applicants, collaboration networks, competitor technology positioning, key inventors and R&D white spaces out of the landscape;
- an on-line access to the selected patent set, so you can visualize, navigate, focus and extract the most relevant patent data according to your specific needs.
To learn more and check available surveys, visit our patent studies page.